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Beyond Chemicals: The Lessons that Toxic Substance
Regulatory Reform Can Learn from Nanotechnology
SCOTT BOMKAMP ∗
INTRODUCTION
Nanotechnology is a revolution in applied science. By manipulating molecules on
the scale of billionths-of-a-meter, scientists have created materials that exhibit “almost
magical feats of conductivity, reactivity, and optical sensitivity, among others.” 1
Nanotechnology also has the potential to drive an economic revolution. Retailers
already sell over 300 products that incorporate nanotechnology, 2 and according to one
estimate, nanotechnology will be a trillion-dollar-a-year industry by 2015. 3 In
congressional testimony, Ray Kurzweil, Chairman and Chief Executive Officer of
Kurzweil Techonologies, asserted that nanotechnology would result in the pervasive
miniaturization of all human industry by the middle of the twenty-first century. 4 Part I
of this Article describes the emerging field of nanotechnology and its applications.
The tremendous economic benefit of nanotechnology, however, will come at a
price. Nanotechnology applications present novel, serious, and possibly irreversible
threats to human health and the environment. Recently, the field of nanotoxicology has
been developed to characterize and quantify these threats. 5 Part II of this Article
discusses the early research demonstrating health and environmental dangers
associated with nanotechnology.
Because of nanotechnology’s mixed blessing, the United States government must
select a strategy to maximize nanotechnology’s economic potential while containing its
health and environmental dangers. Part III of this Article argues that the best strategy is
to incorporate nanotechnology regulation into a general-purpose toxic substances
statute, such as by amending the Toxic Substances Control Act (TSCA), which is
intended to regulate all chemical substances at the point of manufacture. 6

∗ Scott Bomkamp is a law clerk in the Northern District of Ohio Bankruptcy Court and a
2009 graduate of the Indiana University Maurer School of Law. He dedicates this article to his
beautiful wife Kelli, who makes everything possible.
1. Ernie Hood, Nanotechnology: Looking as We Leap, 112 ENVTL. HEALTH PERSP. A740,
A741 (2004).
2. SCI. POLICY COUNCIL, ENVTL. PROT. AGENCY, NANOTECHNOLOGY WHITE PAPER 4
(2007), available at http://epa.gov/ncer/nano/publications/whitepaper12022005.pdf. Consumer
products that contain nanotechnology include socks, cosmetics, and toothpaste. Id. at 11.
3. M.C. Roco, Overview of the National Nanotechnology Initiative (Sept. 10, 2003),
http://www.nsf.gov/crssprgm/nano/reports/nni_overview_rdii.pdf.
4. The Societal Implications of Nanotechnology: Hearing Before the H. Comm. on
Science, 108th Cong. 58 (2003) (statement of Ray Kurzweil), available at
http://commdocs.house.gov/committees/science/hsy86340.000/
hsy86340_0f.htm [hereinafter Statement of Kurzweil].
5. See, e.g., Günter Oberdörster, Eva Oberdörster & Jan Oberdörster, Nanotoxicology: An
Emerging Discipline Evolving from Studies of Ultrafine Particles, 113 ENVTL. HEALTH PERSP.
823 (2005), available at http://www.ehponline.org/members/2005/7339/7339.pdf.
6. Toxic Substances Control Act of 1976, 15 U.S.C. §§ 2601–2692 (2006).
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Part IV of this Article provides background on toxic substances law, and Part V
proposes changes to United States toxic substances law to address nanotechnology’s
threat. Two laws figure heavily into this discussion: TSCA and the European Union
directive, known as Registration, Evaluation, and Authorisation of Chemicals
(REACH). 7 REACH is modeled to a large degree on TSCA, but addresses many of
TSCA’s perceived shortcomings. Congress is considering revising TSCA based on
REACH, which would essentially create a third-generation toxic substances statute. 8
Part V explains that proposed amendments to TSCA based on REACH do an
incomplete job of addressing the threats posed by nanotechnology and makes
suggestions.
I. NANOTECHNOLOGY IS A HETEROGENEOUS GROUP OF TECHNOLOGIES
The United States Environmental Protection Agency (EPA) defines nanotechnology
as:
research and technology development at the atomic, molecular, or macromolecular
levels using a length scale of approximately one to one hundred nanometers [i.e.,
billionths of a meter] in any dimension; the creation and use of structures, devices
and systems that have novel properties and functions because of their small size;
9
and the ability to control or manipulate matter on an atomic scale.

This definition covers both nanomaterials, which are materials with at least one
dimension on a scale of nanometers, and nanotechnology processes, which describes
the direct manipulation of atoms, molecules, or nanomaterials for human purposes. 10
Because the EPA’s definition is so broad, the reader may find some concrete
examples of nanotechnology to be helpful. In 2007, the EPA Nanotechnology White
Paper described four existing categories of nanotechnology (all of which are
nanomaterials):

7. Council Regulation No. 1907/2006, Registration, Evaluation, and Authorisation of
Chemicals (REACH) (EC), available at http://eurlex.europa.eu/LexUriServ/LexUriServ.do
?uri=CELEX:32006R1907:EN:NOT.
8. See infra Part IV.C.
9. SCI. POLICY COUNCIL, supra note 2, at 5. Glenn Harlan Reynolds defines
nanotechnology as “the science and technology of building from the bottom up—one atom or
molecule at a time.” Glenn Harlan Reynolds, Nanotechnology and Regulatory Policy: Three
Futures, 17 HARV. J.L. & TECH. 179, 181 (2003). Scott Segal has described nanotechnology as
being comprised of machines less than 100 nanometers in size. Scott H. Segal, Environmental
Regulation of Nanotechnology: Avoiding Big Mistakes for Small Machines, 1
NANOTECHNOLOGY L. & BUS. 290, 291 (2004). Other commentators describe nanotechnology as
a “heterogeneous family of technologies” without much further elaboration. E.g., Diana M.
Bowman & Graeme A. Hodge, A Small Matter of Regulation: An International Review of
Nanotechnology Regulation, 8 COLUM. SCI. & TECH. L. REV. 1, 2 (2007).
10. See Nakissa Sadrieh & Parvaneh Espandiari, Nanotechnology and the FDA: What Are
the Scientific and Regulatory Considerations for Products Containing Nanomaterials?, 3
NANOTECHNOLOGY L. & BUS. 339, 342 (2006) (distinguishing nanomaterials and
nanotechnology processes).
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Carbon-based materials including “hollow spheres, ellipsoids, and
tubes.” 11 Carbon nanotubes can have enormous tensile strength
and have been used to reinforce building materials. 12 Recently,
scientists created a carbon nanotube structure that absorbed almost
all visible light, making it the world’s “blackest” material. 13 The
optical properties of nanotubes show promise in solar cell
applications. 14

2.

Metal-based materials including quantum dots, which are tiny,
closely-packed semiconductor crystals. 15 They show promise for
use as “qubits” for quantum information processing in the next
generation of computers. 16

3.

Dendrimers, which are tiny, branched structures. 17 They show
promise as vectors for drug delivery. Recently, scientists have
developed “nanobees” which deliver melittin, a toxin present in
bee stings, directly to cancer cells within the human body. 18

4.

Composites of nanomaterials and conventional materials. By
embedding nanotechnology in materials, researchers create new
materials with enhanced physical or chemical properties. 19 One
field involving composites is “nanobiotechnology,” which involves
combining nanomaterials with naturally occurring molecules,
including DNA. 20 These composites may be useful in treating
disease through somatic gene therapy. 21

The EPA predicts that scientists will rapidly create new categories of
nanotechnologies. Future nanotechnology applications may include the following:

11. SCI. POLICY COUNCIL, supra note 2, at 7.
12. B.G. Demczyk, Y.M. Wang, J. Cumings, M. Hetman, W. Han, A. Zettl & R.O. Ritchie,
Direct Mechanical Measurement of the Tensile Strength and Elastic Modulus of Multiwalled
Carbon Nanotubes, 334 MATERIALS SCI. & ENGINEERING APPLICATIONS 173, 173 (2002).
13. Helen Briggs, ‘Darkest Ever’ Material Created, BBC NEWS, Jan. 16, 2008,
http://news.bbc.co.uk/2/hi/science/nature/7190107.stm.
14. Id.
15. SCI. POLICY COUNCIL, supra note 2, at 8.
16. See Daniel Loss & David P. DiVincenzo, Quantum Computation with Quantum Dots,
57 PHYSICAL REV. A 120, 120 (1998), available at http://hep.princeton.edu/~mcdonald/
examples/QM/loss_pra_57_120_98.pdf.
17. SCI. POLICY COUNCIL, supra note 2, at 9.
18. Tumors Feel the Deadly Sting of Nanobees, SCI. DAILY, Aug. 10, 2009,
http://www.sciencedaily.com/releases/2009/08/090810174226.htm.
19. SCI. POLICY COUNCIL, supra note 2, at 10.
20. Kevin Rollins, Nanobiotechnology Regulation: A Proposal for Self-Regulation with
Limited Oversight, 6 NANOTECHNOLOGY L. & BUS. 221, 221 (2009).
21. Id. at 223.

2010]

BEYOND CHEMICALS
1.

Molecular assemblers. A molecular assembler is a device used to
assemble bulk-scale materials molecule-by-molecule (that is, through
a nanotechnology process). 22 In the future, molecular assembly may
allow the assembly of large goods such as cars, airplanes and
buildings molecule-by-molecule and without the assistance of human
workers. 23

2.

Nanorobotics. Researchers are attempting to engineer robots on a
nanometer scale. 24 These robots may be useful in performing surgery
within the human body. 25

3.

Imaging technologies. Nanotechnology may lead to the next
generation of television. Researchers are currently attempting to
create holograms by manipulating molecules in the gas phase. 26

27

II. THE HEALTH AND ENVIRONMENTAL DANGERS OF NANOTECHNOLOGY
“Nanotoxicology” is defined as the “science of engineered nanodevices and
nanostructures that deals with their effects in living organisms.” 27 Because
nanotoxicology is a new field, detailed heath and safety data for many nanotechnology
applications is nonexistent. 28 However, existing nanotoxicology research suggests at
least three themes that tend to make nanotechnology applications more dangerous than
ordinary materials.
First, because of their small size, nanotechnology applications can pass through the
protective membranes of the human body, including the cell membranes of the skin,
gastrointestinal tract, and lungs. 29 Nanomaterials have even been shown to cross the
blood/brain barrier in rats, which is regarded as the body’s tightest junction. 30 Once
nanomaterials penetrate the body’s outer defenses, they can migrate to the blood stream
or lymph system, circulate throughout the human body, and deposit in organs, tissues,
and cells, where they bioaccumulate. 31
Second, nanotechnology applications have higher chemical activity than ordinary
materials. This higher activity is due to the fact that small objects (such as

22. See Reynolds, supra note 9, at 185.
23. See id. at 186.
24. See SCI. POLICY COUNCIL, supra note 2, at 12.
25. Oberdörster et al., supra note 5, at 824 (discussing the use of nanorobots for targeted
drug delivery).
26. Christopher R. Moon, Lalia S. Mattos, Brian K. Foster, Gabriel Zeltzer & Hari C.
Manoharan, Quantum Holographic Encoding in a Two-Dimensional Electron Gas, 4 NATURE
NANOTECHNOLOGY 167 (2009).
27. Oberdörster et al., supra note 5, at 824.
28. See, e.g., id. at 828.
29. Id. at 829–35 (summarizing research on how nanoparticles infiltrate and circulate
through the body).
30. G. Oberdörster, Z. Sharp, V. Atudorei, A. Elder, R. Gelein, W. Kreyling & C. Cox,
Translocation of Inhaled Ultrafine Particles to the Brain, 16 INHALATION TOXICOLOGY 437, 441
(2004) (showing translocation of nanoparticles into the brains of rats).
31. Oberdörster et al., supra note 5, at 829.
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nanomaterials) have much higher surface area per unit volume than large objects (such
as conventional materials). 32 Because chemical reactions usually occur at exposed
surfaces, nanomaterials are much more chemically reactive, and thus more toxic, than
ordinary materials. 33 For example, as a result of its high surface area, inhaled nanoscale
titanium dioxide, which is used in sunscreens, has been shown to generate a greater
inflammatory response than ordinary titanium dioxide. 34
Third, nanotechnology applications behave in unpredictable (even “magical”) ways
because the laws of quantum mechanics, as opposed to Newtonian physics, become
increasingly important with diminishing size. 35 As a result, nanomaterials are toxic by
different mechanisms than their bulk-scale counterparts. For example, a study found
that nanoscale iron oxide was extremely toxic by an unknown mechanism. 36 In
summary, nanomaterials may infiltrate the body in higher-than-expected numbers,
reach unexpected parts of the body, bioaccumulate throughout the body, be more toxic
than expected, and cause toxic effects of a completely different character than those
associated with ordinary substances of the same chemical identity.
Future nanotechnology applications also will present other dangers. Currently,
toxicological data only exists for “first generation” nanotechnology applications, which
generally consist of small particles. 37 The EPA predicts that by 2015 it may be possible
to design nanosized robots. 38 Eric Drexler has expressed concern that uncontrolled
self-replication of nanorobots could result in uncontrolled molecular nanotechnology
chewing the world down to “grey goo.” 39 Of course, no one knows if this could
actually happen. However, the “grey goo” hypothetical does illustrate that highergeneration nanotechnologies will present novel risks.
III. THE CASE FOR AMENDING TSCA TO REGULATE NANOTECHNOLOGY
Several commentators have argued that Congress should pass a nanotechnologyspecific law. 40 This Part argues that nanotechnology should be regulated under a
general-purpose toxic substances law, such as TSCA, for two reasons: first, because the
subject matter of a “nanotechnology” statute may be difficult or impossible to define;

32. Id. at 825 tbl.2 (illustrating the relationship between diameter and surface area).
33. Id. at 823.
34. Id. at 826.
35. See SCI. POLICY COUNCIL, supra note 2, at 13.
36. Tobias J. Brunner, Peter Wick, Pius Manser, Philipp Spohn, Robert N. Grass, Ludwig
K. Limbach, Arie Bruinink & Wendelin J. Stark, In Vitro Cytotoxicity of Oxide Nanoparticles:
Comparison to Asbestos, Silica, and the Effect of Particle Solubility, 40 ENVTL. SCI. & TECH.
4374, 4379 (2006).
37. See SCI. POLICY COUNCIL, supra note 2, at 12–13 (explaining the need for the EPA to
have the flexibility to adjust to changing generations of nanotechnology).
38. Id. at 13.
39. K. ERIC DREXLER, ENGINES OF CREATION 171–90 (1986).
40. See, e.g., J. CLARENCE DAVIES, MANAGING THE EFFECTS OF NANOTECHNOLOGY 10
(2006), available at http://www.wilsoncenter.org/index.cfm?fuseaction=news.item&news_id=
165552 (proposing a nanotechnology-specific law); Albert C. Lin, Size Matters: Regulating
Nanotechnology, 31 HARV. ENVTL. L. REV. 349, 391–407 (2007) (proposing a new law
requiring that manufacturers of certain nanotechnologies post environmental bonds).
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and second, because passing a law to regulate nanotechnology alone might leave the
EPA unable to regulate future technologies.
A. The Trouble with Defining Nanotechnology
Nanotechnology has proven difficult to define for regulatory purposes. 41 As
discussed, the EPA’s definition of nanotechnology is so broad that it fails to
communicate a concrete definition of what nanotechnology is.42 In addition, it contains
ambiguities. For example, are naturally occurring structures, such as pollen or the
scales on butterfly wings considered nanotechnology? What about nanosized structures
that are covered by another scientific discipline, such as peptides (biotechnology) or
tiny transistors (computer science)?
Commentators have advanced many definitions of nanotechnology. 43 But these
definitions are all problematic because they are either too narrow to cover the full
range of what is considered nanotechnology or too broad to concretely convey what
nanotechnology is. 44 No one yet has defined nanotechnology in a way that is both
broad and specific.
However, defining the precise bounds of “nanotechnology” would not be necessary
if nanotechnology regulation was incorporated into a broader toxic substances statute,
such as TSCA. Part V of this Article argues that Congress should amend TSCA to
allow the EPA to regulate all novel materials as unique substances, without requiring
the EPA to make the finding that the materials are a form of nanotechnology. As a
result, this approach completely avoids the thorny issue of defining nanotechnology.
B. Limiting a Statute Only to Nanotechnology Would Fail to Protect Society
Against Future Technologies
Passing environmental reform is a politically expensive proposition. Congress has
not passed a significant new environmental law since the environmental decade from
1970 to 1980. 45 Thus, to adequately protect the public, Congress should pass toxic
substances reform that is flexible enough to regulate future technologies. A

41. See DAVIES, supra note 40, at 8 (“The answer to the definitional question—whether
regulators and those regulated will be able to make a clear demarcation between what is and
what isn’t considered [nanotechnology]—will depend on the details of the definition and the
technical capability for applying it.”).
42. See supra Part I.
43. See supra note 9.
44. For example, Scott Segal defines nanotechnology as machines that are less than 100
nanometers in size. Segal, supra note 9, at 291. This definition is too narrow because it ignores
currently existing nanotechnology applications such as nanocomposites as well as potential
future nanotechnologies such as molecule-by-molecule assemblers. See supra Part I. By
contrast, other commentators describe nanotechnology as a “heterogeneous family of
technologies” without further elaboration. Bowman & Hodge, supra note 9, at 2. Such a
definition does not convey any definite idea of what nanotechnology is.
45. See John S. Applegate, The Taming of the Precautionary Principle, 27 WM. & MARY
ENVTL. L. & POL’Y REV. 13, 72 (2002).
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nanotechnology-specific law would not provide protection against future regulatory
gaps.
For example, imagine that scientists develop an economically promising but
dangerous technology called “xenotechnology.” Scientists agree that xenotechnology is
not nanotechnology, but it has characteristics that make it difficult to regulate under
existing toxic substances law. In this case, a nanotechnology-specific law would not be
adequate to protect society from xenotechnology. Part V of this Article proposes
reforms to general toxic substances law that are adequate to deal with future
technologies.
IV. FROM TSCA TO REACH AND BACK AGAIN: RECENT DEVELOPMENTS IN TOXIC
SUBSTANCES LAW
This Part provides background on current toxic substances law. In particular, it
describes the complicated relationship between TSCA and the European Union
directive known as REACH.
A. TSCA and Its Discontents
TSCA is the most important toxic substances law in the United States because it
regulates chemicals at the point of manufacture. 46 The core of TSCA is its section 5
requirement that manufacturers of a chemical substance submit a pre-manufacture
notice (PMN) to the EPA ninety days before producing a “new chemical substance.”47
If the EPA objects to the manufacture of the substance, section 6 of TSCA gives the
EPA the power to issue a rule preventing or limiting the manufacture. 48 TSCA also
gives the EPA the power to limit the distribution or use of a chemical substance at any
point in the chain of commerce, require the use of warnings on the packaging of the
chemical substance, 49 or require manufacturers of a new or existing chemical to
perform testing to generate health or environmental data. 50 In summary, TSCA would
seem to grant the EPA far-reaching powers to regulate chemical substances.
Nonetheless, TSCA has been an underachiever among U.S. environmental laws.
TSCA requires the EPA to expend considerable resources before it can take any
regulatory action. For example, to place restrictions on a chemical under section 6, the
burden is on the EPA to demonstrate that a chemical is an “unreasonable risk.” 51
Federal courts have interpreted the unreasonable risk standard to require the agency to
perform a wide-ranging cost-benefit analysis before regulating even the most
dangerous chemicals. 52 In fact, the EPA has used its section 6 authority only four times

46. See 15 U.S.C. § 2604 (2006) (requiring notice prior to manufacture). By comparison,
media-based statutes, such as the Clean Water Act and Clean Air Act, and use-based statutes,
such as the Federal Insecticide, Fungicide, and Rodenticide Act are much narrower in scope.
DAVIES, supra note 40, at 14–15.
47. 15 U.S.C. § 2604(a).
48. 15 U.S.C. § 2605(a) (2006).
49. Id. § 2605(a)(2)–(3).
50. 15 U.S.C. § 2603 (2006).
51. 15 U.S.C. § 2605(a).
52. See, e.g., Corrosion Proof Fittings v. EPA, 947 F.2d 1201, 1223 (5th Cir. 1991).
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to limit the use of chemicals and has never successfully used its section 6 authority to
ban the manufacture of a chemical. 53
For example, consider the EPA’s efforts to regulate asbestos. The history of
asbestos regulation has special relevance to current efforts to regulate nanotechnology.
In fact, if it were developed today, asbestos likely would be considered nanotechnology
because asbestos consists of nanoscale ceramic fibers. 54 And like modern
nanotechnology applications, asbestos was the “miracle material” of its day. In the
mid-twentieth century, asbestos was prized for its fire-resistance and was widely used
in applications including insulation, brake pads, and fire blankets. 55 By the 1960s,
strong evidence existed that corocidolite asbestos was a potent carcinogen. 56 Today,
the World Health Organization estimates that currently, 125 million individuals are
occupationally exposed to asbestos. 57
The EPA studied the health effects of asbestos for ten years, conducted over one
hundred human health studies, and issued a TSCA section 6 rule banning the use of
asbestos. 58 Despite the EPA’s exhaustive investigation, the Fifth Circuit struck down
most of the EPA’s rule because the court determined that the EPA had not
demonstrated that asbestos causes an “unreasonable risk.” 59 The court found that the
EPA failed to consider regulatory alternatives to a total ban, failed to consider the
toxicity of products that would be used to replace asbestos, and failed to follow
TSCA’s procedural provisions. 60
In addition, TSCA is ineffective at gathering information about the chemicals it
regulates. The EPA must meet the burden of demonstrating that a chemical “may
present an unreasonable risk” before it can order testing. 61 This puts the EPA in a
catch-22: the agency is required to produce information it does not have to learn what
it does not know. A 1984 study found that no toxicity data was available for more than
eighty percent of toxic chemicals in commerce and that toxicity data were available for
only twenty-two percent of high volume chemicals. 62
The EPA has relied on voluntary programs because of the high evidentiary standard
imposed by TSCA. In 2008, the EPA launched the Nanotechnology Materials
Stewardship Program to learn about the types of nanoscale materials under
development, develop risk management practices, encourage the development of health
and environmental test data, and encourage the responsible development of

53. LYNN L. BERGESON, TSCA: TOXIC SUBSTANCES CONTROL ACT 48–49 (2000).
54. Brunner et al., supra note 36, at 4379–80. For this reason, asbestos fibers are often used
as a positive control in in vitro nanotoxicology studies. See, e.g., id.
55. EPA, Asbestos: Basic Information, http://www.epa.gov/asbestos/pubs/help.html.
56. P.W.J. Bartrip, History of Asbestos Related Disease, 80 POSTGRADUATE MED. J. 72, 72
(2004), available at http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1742940.
57. WORLD HEALTH ORG., ELIMINATION OF ASBESTOS-RELATED DISEASES 1 (2006),
http://www.who.int/occupational_health/publications/asbestosrelateddiseases.pdf.
58. John S. Applegate, Bridging the Data Gap: Balancing the Supply and Demand for
Chemical Information, 86 TEX. L. REV. 1365, 1386 (2008).
59. Corrosion Proof Fittings v. EPA, 947 F.2d 1201, 1222–23 (5th Cir. 1991).
60. Id. at 1214–30.
61. 15 U.S.C. § 2603(a)(1)(A)(i) (2006).
62. John S. Applegate, Synthesizing TSCA and REACH: Practical Principles for Chemical
Regulation Reform, 35 ECOLOGY L.Q. 721, 734–36 (2008).
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nanotechnologies. 63 Unfortunately, companies have been selective in reporting
information to the program. The program’s 2009 Interim Report states that the EPA
has received very little health and safety data about nanomaterials. 64 This failure
suggests that voluntary programs alone will be inadequate to address the threats posed
by nanotechnology.
B. REACH as a Reaction to TSCA
In 2006, the European Union enacted the directive known as REACH, which
provides a comprehensive framework for the regulation of chemicals throughout
Europe. 65 REACH was written as a response to the regulatory paralysis created by
TSCA, 66 as well as more uniquely European concerns, such as reducing animal testing
and harmonizing European toxic substances law. 67
REACH explicitly incorporates the precautionary principle. 68 Fundamentally, a
“precautionary approach” to regulation requires that technologies with an uncertain
impact on human health or the environment be restricted until the uncertainty is
resolved. 69 It reflects the normative belief that protection of human health and
environmental concerns trump concerns about economic efficiency. 70 It also reflects
the factual assumption that “new technologies will create novel, severe, and
irreversible . . . harms to human health and the environment” unless preventive
measures are taken. 71
REACH’s data gathering provisions reflect this precautionary approach. REACH
places the burden of producing health and environmental data on prospective chemical
manufacturers. 72 Prospective manufacturers must submit dossiers of health and
environmental data for any chemical to be manufactured in an amount greater than ten
metric tons. 73 Recent EU policy guidance makes clear that the report must include
information on all known uses of the chemical, including the conversion of the

63. U.S. ENVTL. PROT. AGENCY, CONCEPT PAPER FOR THE NANOSCALE MATERIALS
STEWARDSHIP PROGRAM UNDER TSCA 1–2 (2008), available at http://www.epa.gov/opptintr/
nano/nmsp-conceptpaper.pdf.
64. See U.S. ENVTL. PROT. AGENCY, NANOSCALE MATERIALS STEWARDSHIP PROGRAM
INTERIM REPORT 9 (2009), available at http://www.epa.gov/oppt/nano/nmsp-interim-reportfinal.pdf [hereinafter INTERIM REPORT].
65. Applegate, supra note 62, at 723.
66. Id. (“[T]he Commission’s White Paper can be read as an extended critique of TSCA,
and REACH as the legislative product of that critique.”).
67. Id. at 741.
68. Council Regulation No. 1907/2006, supra note 7, art. 1, para. 3. (“This Regulation is
based on the principle that it is for manufacturers, importers and downstream users to ensure
that they manufacture, place on the market or use such substances that do not adversely affect
human health or the environment. Its provisions are underpinned by the precautionary
principle.”).
69. Applegate, supra note 45, at 13.
70. Id.
71. Id.
72. Applegate, supra note 62, at 743.
73. Council Regulation No. 1907/2006, supra note 7, art. 10.
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chemical into nanomaterials. 74 Thus, REACH is expected to generate a large amount of
health and environmental data about chemicals.
REACH’s provisions for the authorization of chemical manufacture also reflect the
precautionary principle. The precautionary approach is strongest in the case of
chemicals that are designated to be of Very High Concern (VHC) because of
carcinogenic, mutagenic, or bioaccumulative properties. 75 In the case of VHC
chemicals, the manufacturer must receive express permission to begin or continue
production. 76 To receive this permission, the manufacturer must demonstrate that no
safer chemical exists and present a research plan to find alternatives. 77 Furthermore, if
the release of the chemical into the environment cannot be “adequately controlled” the
manufacturer must demonstrate that the benefits of producing the chemical outweigh
the costs. 78
In the case of non-VHC chemicals, REACH takes a somewhat less precautionary
approach. Article 69 states that a chemical will be restricted if the “dossier
demonstrates that action on a Community-wide basis is necessary.” 79 Thus, the text of
REACH does not clearly allocate the burden of proving safety between the agency and
the manufacturer. However, the procedure for restricting a chemical is very
complicated, and compliance places a substantial burden on the agency. 80
C. The Movement for REACH-Based Reforms to TSCA
TSCA reform, based on REACH, is a realistic prospect in near future. In February
2009, the House Subcommittee on Commerce Trade and Consumer Protection held a
hearing entitled “Revisiting the Toxic Substances Control Act of 1976.” 81 The
subcommittee discussed TSCA’s well-known problems, including the “unreasonable
risk” standard for chemical regulation, its ineffectiveness at collecting information, and
its procedural complexity. 82 Regulatory reform based on REACH was discussed as a
way to correct these shortcomings. 83 Part V of this Article discusses the implications of
REACH-based reform for nanotechnology regulation.

74. EUROPEAN COMM’N, FOLLOW-UP TO THE 6TH MEETING OF THE REACH COMPETENT
AUTHORITIES FOR THE IMPLEMENTATION OF REGULATION (EC) 1907/2006 (REACH) 6 (2008),
available at http://ec.europa.eu/environment/chemicals/reach/pdf/nanomaterials.pdf.
75. See Applegate, supra note 62, at 742–73 (citing Council Regulation No. 1907/2006,
supra note 7, arts. 55–66).
76. Id.
77. Id.
78. Council Regulation No. 1907/2006, supra note 7, at art. 60, paras. 2, 4; see also
Applegate, supra note 62, at 742–73.
79. Council Regulation No. 1907/2006, supra note 7, at art. 69 para. 3.
80. Applegate, supra note 58, at 746–47.
81. Revisiting the Toxic Substances Control Act of 1976: Hearing Before the H. Subcomm.
on Commerce, Trade, and Consumer Protection of the H. Comm. on Energy and Commerce,
111th Cong. (2009), available at http://energycommerce.house.gov/index.php?option=
com_content&task=view&id=1505&Itemid=95.
82. Id. (statement of John Stephenson, U.S. Gov’t Accountability Office), available at
http://energycommerce.house.gov/Press_111/20090226/testimony_gao.pdf.
83. See, e.g., id. at 4.

34

INDIANA LAW JOURNAL SUPPLEMENT

[Vol. 85:24

V. REGULATION OF NANOTECHNOLOGY: IMPLICATIONS OF REACH-BASED REFORM
TO TSCA
This Part discusses both the strengths and weaknesses of REACH-based reform to
TSCA and discusses ways in which a third-generation toxic substances statute could be
written to meet the health and environmental challenges posed by nanotechnology.
A. Strengths of REACH-Based Reform to TSCA
1. REACH’s Precautionary Approach Is Appropriate for Nanotechnology
Preliminary research into the health and environmental effects of nanotechnology
supports the precautionary principle’s factual assumptions that new technologies create
novel, severe, and irreversible harms. The physical and chemical properties of
nanotechnology are novel because they are different than the properties of existing
materials with the same chemical composition. 84 The high-surface area and resulting
high chemical reactivity of nanomaterials leads to severe health and environmental
consequences. 85 Finally, the tendency of nanomaterials to bioaccumulate throughout
the body (and the possibility of uncontrolled self-replicating nanotechnologies)
supports the conclusion that nanotechnology contamination is irreversible. 86
Furthermore, society’s experience with asbestos should be taken into account
because, as discussed, asbestos shares characteristics with nanotechnology.87 Asbestos
has characteristics that are both “magical” and dangerous. During the first half of the
twentieth century, industry moved full-speed ahead because of the potential for
economic gain, but, by the later half of the twentieth century, society learned that the
use of asbestos resulted in a net loss. Thus, society’s experience with asbestos suggests
that the precautionary approach taken by REACH is appropriate for nanotechnology.
2. REACH’s Mandatory Information Gathering Provisions are Appropriate for
Nanotechnology
Very little is known about the health and environmental risks of most
nanotechnology applications for at least two reasons. First, the EPA has only limited
information about the types of nanotechnologies under development by private
industry. At the present time, EPA knowledge is limited to the voluntary submissions
of sixteen companies under the auspices of the Nanotechnology Stewardship
Program. 88 Second, the EPA has very limited health and safety information regarding
known nanotechnology applications. Even companies participating in the Stewardship
Program have not provided the EPA health and environmental data. 89

84.
85.
86.
87.
88.
89.

See supra Part II.
See supra Part II.
See supra Part II.
See supra Part IV.A.
INTERIM REPORT, supra note 64, at 9.
Id. at 11.
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TSCA is inadequate to close these data gaps for at least two reasons. First, TSCA’s
PMN requirement applies only to “new” and not “existing” chemicals. 90 The EPA
treats a chemical as existing if it is listed on TSCA’s Chemical Substance Inventory. 91
As a result, nanotechnology versions of chemicals that are already listed on the
Inventory are not subject to the PMN requirement. 92 Thus, the EPA is not informed
when a novel nanotechnology application is manufactured if it is manufactured from an
existing chemical. Second, even if the EPA was informed about the existence of a
novel nanotechnology application, it would be unable to require health and
environmental testing because of TSCA’s demanding evidentiary requirements. 93
REACH provides much better tools to close the nanotechnology data gap. As
discussed, REACH requires prospective manufacturers to submit dossiers disclosing
any nanotechnology uses of manufactured chemicals. 94 Furthermore, manufacturers
must produce health and safety data regarding those uses. 95 Thus, REACH-based
reform of United States toxic substances law would result in the generation of muchneeded health and environmental data regarding nanotechnology.
3. TSCA Provides Flexibility in Regulating Chemicals
As discussed in Part I, nanotechnology is extremely heterogeneous. Future
applications of nanotechnology will be as diverse as processes for the molecule-bymolecule assembly of large-scale consumer goods (such as vehicles), 96 implants that
will allow the human brain to interface with external technology, 97 and tiny machines
that will be able to remediate toxic waste sites. 98 This diversity suggests that the EPA
should have the authority to assess nanotechnology applications on a case-by-case
basis and take whatever action is appropriate to protect the public.
TSCA’s strength is its flexibility. As discussed, TSCA provides the EPA with a
wide selection of actions to restrict chemicals at any point in the chain of commerce. 99
(Of course, EPA’s power to take these actions is undercut by TSCA’s lack of
precaution, which is a separate issue.) 100 A third-generation toxic substances statute
should maintain TSCA’s flexibility of response to effectively regulate diverse forms of
nanotechnology.

90. U.S. ENVTL. PROT. AGENCY, TSCA INVENTORY STATUS OF CHEMICAL SUBSTANCES—
GENERAL APPROACH 1–2 (2008), available at http://www.epa.gov/oppt/nano/nmspinventorypaper2008.pdf [hereinafter General Approach].
91. Id.
92. Id.
93. See supra Part IV.A.
94. See supra Part IV.B.
95. See supra Part IV.B.
96. See Reynolds, supra note 9, at 181.
97. See Statement of Kurzweil, supra note 4, at 34–36.
98. Pratim Biswas & Chang-Yu Wu, Nanoparticles and the Environment, 55 J. AIR &
WASTE MGMT. ASS’N 708, 710 (2005).
99. See supra Part IV.A.
100. See supra Part IV.A.
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B. Problems with REACH-Based reform of TSCA
1. Definition of Subject Matter
Both TSCA and REACH define their subject matter in a way that would make it
difficult to regulate nanotechnology. TSCA defines “chemical substances” to mean
“any organic or inorganic substance of a particular molecular identity . . . .” 101 The
EPA interprets “molecular identity” to mean “the types and number of chemical bonds,
the connectivity of the atoms in the molecule, and the spatial arrangement of the atoms
within the molecule.” 102 In other words, under TSCA, “chemical substances” are
defined in terms of “molecules,” which are arrangements of atoms. Unfortunately,
nanotechnology applications are often defined by arrangements of molecules—that is,
arrangements at a higher structural level than the definition of chemical substances in
TSCA can capture. 103
As a result, many nanomaterials are not recognized as “new chemical substances”
subject to PMN reporting. For example, consider nanoscale titanium dioxide. Titanium
dioxide is an “existing” chemical for purposes of TSCA. 104 Therefore, a producer of
nanoscale titanium dioxide is not required to give premanufacture notice. This is true
even though nanoscale titanium dioxide is used in sunscreens precisely because of its
novel physical and chemical properties. 105
In a handful of cases, the EPA has stretched the meaning of “chemical substances”
to include structures that, like nanotechnology, are organized above the atomic level.
For example, the EPA has asserted that the definition of chemical substances is broad
enough to cover microorganisms, which can hardly be described as molecules. 106 This
broad approach is also found in EPA’s definition of Class 2 chemical substances,
which are defined as having a chemical composition that “cannot be fully represented
by a complete, specific chemical structure diagram.” 107
However, these designations have not been challenged in court. If they were, they
might be struck down. Courts typically review agency definitions of terms in statutes
with Chevron 108 deference. 109 Under Chevron deference, the reviewing court will
typically uphold the agency’s interpretation unless it is counter-textual.110 However, in
this case, the plain language of the statute, which requires substances to be “of a

101.
102.
103.
104.

15 U.S.C. § 2602(2)(A) (2006) (emphasis added).
GENERAL APPROACH, supra note 90, at 3.
See id. at 4.
See U.S. ENVTL. PROT. AGENCY, NANOMATERIAL CASE STUDIES: NANOSCALE TITANIUM
DIOXIDE IN WATER TREATMENT AND IN TOPICAL SUNSCREEN 1-5 to 1-6 (2009).
105. Id. at 1-7.
106. See 40 C.F.R. §§ 700, 720–21, 723, 725 (1997) (“TSCA defines ‘chemical substance’
broadly and in terms which cover microorganisms as well as traditional chemicals.”).
107. 40 C.F.R. § 720.45(a)(1)(i) (2008).
108. Chevron U.S.A., Inc. v. Natural Resources Defense Council, Inc., 467 U.S. 837 (1984).
109. E.g., Timothy K. Armstrong, Chevron Deference and Agency Self-Interest, 13 CORNELL
J.L. & PUB. POL’Y 203, 204–07 (2004).
110. Id.
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particular molecular identity,” 111 is clearly a problem in the context of novel substances
that are defined by more than the connectivity of their atoms.
Unfortunately, the definition of “substance” in REACH also lacks the scope to
regulate most nanotechnology. “Substance” is defined to mean:
a chemical element and its compounds in a natural state or obtained by any
manufacturing process, including any additive necessary to preserve its stability
and any impurity deriving from the process used, but excluding any solvent which
may be separated without affecting the stability of the substance or changing its
112
composition.

A recent EU policy document is cryptic about whether this definition is sufficient to
distinguish nanotechnology from ordinary materials. 113
Thus, neither TSCA nor REACH contains a definition of subject matter that is
adequate to regulate nanotechnology. The definition of subject matter in a thirdgeneration toxic substances statute should avoid limiting language such as “of a
particular molecular identity” or “a chemical element and its compounds.” A suggested
definition for “substances” would be: any state of matter, combined or uncombined, as
distinguished by any physical or chemical property, or any process for the production
of such a state of matter.
2. Chemical Safety Reports Should Not Be Limited to High Volume Chemicals
As discussed in Part II, nanotechnology applications can be much more toxic per
unit mass than ordinary chemicals. Thus, the assumption that low volumes of chemicals
are not dangerous is not valid for nanotechnology. Unfortunately, both REACH and
TSCA incorporate this assumption.
REACH contains an exemption for chemicals that are manufactured in amounts less
than ten metric tons per year. 114 The EPA has also implemented a Low Volume
Exemption under TSCA, which exempts manufacturers who produce less than 10
metric tons of chemical per year from PMN requirements. 115 A third-generation toxic
substances statute should avoid incorporating the assumption that low volumes of
chemicals will have a de minimus environmental impact.
CONCLUSION
For many years reformers from the academic, regulatory, and environmental
communities have been drawing up plans to improve or replace TSCA. In many ways,

111. 15 U.S.C. § 2602(2)(A) (2006).
112. Council Regulation No. 1907/2006, supra note 7, at art. 3(1) (emphasis added).
113. EUROPEAN COMM’N, supra note 74, at 13 (“Overall, the Commission services recognise
that those issues require further consideration with a view to getting a solid understanding of the
current regulatory coverage of REACH and identifying any need for further review at a
subsequent stage.”).
114. Council Regulation No. 1907/2006, supra note 7, at art. 14(1).
115. 40 C.F.R. § 723.50 (1995); see also EPA, Low Volume Exemptions,
http://www.epa.gov/oppt/newchems/pubs/backlvem.htm.
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the enactment of REACH was a victory for these reformers. Understandably, they want
to seize the momentum and make similar changes to toxic chemicals regulation in the
United States.
But nanotechnology is a game-changer. Nanotechnology challenges the very
definition of what chemicals are. Furthermore, many of the ideas that reformers have
developed in the decades after the enactment of TSCA do not adequately take account
of nanotechnology. As a result, proposed reforms need to be reevaluated. If this is
done, the result will be a third-generation toxic substances statute that both overcomes
TSCA’s legacy of failure and looks forward to the technological future.

